- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 209/46 - Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
Patent holdings for IPC class C07D 209/46
Total number of patents in this class: 370
10-year publication summary
|
30
|
31
|
22
|
29
|
23
|
19
|
18
|
15
|
23
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2943 |
20 |
| Celgene Corporation | 1468 |
15 |
| AstraZeneca AB | 2958 |
11 |
| Nerviano Medical Sciences S.r.l. | 256 |
9 |
| Plastipak Packaging, Inc. | 332 |
9 |
| SABIC Global Technologies B.V. | 4203 |
8 |
| Bristol-myers Squibb Company | 4863 |
7 |
| Amgen Inc. | 3899 |
7 |
| ChemoCentryx, Inc. | 393 |
7 |
| VALO Health, Inc. | 168 |
6 |
| SHPP Global Technologies B.V. | 1059 |
6 |
| Merck Sharp & Dohme LLC | 3751 |
6 |
| The University Court of the University of Aberdeen | 122 |
5 |
| CNG Bio Co., Ltd. | 9 |
5 |
| Sabic Innovative Plastics IP B.V. | 683 |
4 |
| Korea Advanced Institute of Science and Technology | 4188 |
4 |
| AnaSpec Incorporated | 27 |
4 |
| Chungbuk National University Industry-Academic Cooperation Foundation | 216 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
4 |
| Institute for Basic Science | 332 |
4 |
| Other owners | 225 |